Last updated on August 2020

High Strength Cranberry Supplementation for Prevention of Recurrent Urinary Tract Infection


Brief description of study

This clinical trial is a Phase 2, multicenter, placebo-controlled, double-blind, parallel-arm study to evaluate the efficacy and safety of High Strength Cranberry (500mg Pacran) in preventing UTI (cystitis) in women with a history of recurrent UTI (rUTI).

Clinical Study Identifier: NCT03042273

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.